Form 8-K - Current report:
SEC Accession No. 0001104659-25-018320
Filing Date
2025-02-27
Accepted
2025-02-27 17:19:25
Documents
15
Period of Report
2025-02-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257830d1_8k.htm   iXBRL 8-K 45123
2 EXHIBIT 99.1 tm257830d1_ex99-1.htm EX-99.1 20374
6 GRAPHIC tm257830d1_ex99-1img001.jpg GRAPHIC 4463
  Complete submission text file 0001104659-25-018320.txt   259298

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA enfn-20250226.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20250226_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20250226_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm257830d1_8k_htm.xml XML 3801
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 25680737
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)